Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression
Enrique Lara-Pezzi, … , Alicia G. Arroyo, Manuel López-Cabrera
Enrique Lara-Pezzi, … , Alicia G. Arroyo, Manuel López-Cabrera
Published December 15, 2002
Citation Information: J Clin Invest. 2002;110(12):1831-1838. https://doi.org/10.1172/JCI15887.
View: Text | PDF
Article Infectious disease

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

  • Text
  • PDF
Abstract

Research Article

Authors

Enrique Lara-Pezzi, Maria Victoria Gómez-Gaviro, Beatriz G. Gálvez, Emilia Mira, Miguel A. Iñiguez, Manuel Fresno, Carlos Martínez-A., Alicia G. Arroyo, Manuel López-Cabrera

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Induction of MMP-2 activation, MT1-MMP expression, and cell invasion by ...
Induction of MMP-2 activation, MT1-MMP expression, and cell invasion by HBx is sensitive to the COX-2 inhibitor NS398. (a) For 24 hours, CMX cells were grown in the presence of increasing amounts, and HepG2 and 2.2.15 cells were grown in the presence of 100 μM, of the COX-2–specific inhibitor NS398, along with 10 μM PGE2 where indicated. The presence of activated MMP-2 in the cell lysates was analyzed by Western blot. (b) CMO, CMX, HepG2, and 2.2.15 cells, as well as 4pX cells in which HBx expression was induced by removing tetracycline (Tet) for 24 hours, were treated or not treated with 100 μM NS398 for 24 hours and lysed, and the amount of MT1-MMP protein was studied by Western blot. (c) CMX and CMO cells were treated or not treated with 100 μM NS398 for 24 hours, and the expression of MT1-MMP transcripts was analyzed by quantitative RT-PCR. (d) CMO, CMX, HepG2, 2.2.15, or 4pX cells (with or without tetracycline) were allowed to invade Matrigel-coated Transwells in the presence of 100 μM NS398, or DMSO as a control, and 10 μM PGE2 where indicated. Cells that migrated to the lower chamber were quantified as in Figure 1.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts